Overview
Michael Whyte is an Endocrinologist in Saint Louis, Missouri. Dr. Whyte and is rated as an Advanced provider by MediFind in the treatment of SOST-Related Sclerosing Bone Dysplasia. His top areas of expertise are Hypophosphatasia (HPP), Juvenile Paget's Disease, Rickets, Hypophosphatemia, and Leg or Foot Amputation. Dr. Whyte is currently accepting new patients.
His clinical research consists of co-authoring 131 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of SOST-Related Sclerosing Bone Dysplasia.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Medica
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Elite
- Childhood Hypophosphatasia (HPP)
- Hypercalcemia
- Hypophosphatasia (HPP)
- Hypophosphatemia
- Juvenile Paget's Disease
- Malnutrition
- Advanced
- Calcinosis
- Melorheostosis with Osteopoikilosis
- Osteogenesis Imperfecta
- Osteomesopyknosis
- Osteopetrosis Autosomal Recessive Type 3
- Osteopoikilosis
- Experienced
- Familial Hypocalciuric Hypercalcemia Type 1
- Hypoparathyroidism
- Leg or Foot Amputation
- Mast Cell Activation Syndrome (MCAS)
- Melorheostosis
- Nephrocalcinosis